Proto Labs Inc: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Feb 27, 2015 and accepted by EDGAR at Feb 27, 2015, 11:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2014-01-01 to 2014-12-31 | $209.6m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $81.2m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $128.4m | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $16.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | $60.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $18.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2014-01-01 to 2014-12-31 | $41.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | $1.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | $1.62 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 26,100,320 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $57.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $43.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-12-31 | $43.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $108.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $287.5m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $18.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $22.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-12-31 | $265.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-15-003620. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.